+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Safety Testing Market - Global Forecast 2026-2032- Product Image
Biologics Safety Testing Market - Global Forecast 2026-2032- Product Image
Sale

Biologics Safety Testing Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989657
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biologics Safety Testing Market is projected to reach USD 5.37 Billion in 2026. It is expected to continue growing at a CAGR of 11.03%, reaching USD 10.09 Billion by 2032.

Biologics safety testing is a mission-critical quality and regulatory function for monoclonal antibodies, recombinant proteins, vaccines, biosimilars, cell therapies, gene therapies, and other complex biopharmaceutical products. The field covers sterility testing, endotoxin testing, mycoplasma testing, viral safety testing, adventitious agent detection, cell line characterization, residual host cell protein and DNA analysis, bioburden testing, and product-specific potency and impurity assessments.

Demand is being reinforced by the global expansion of biologics pipelines, higher biosimilar development activity, and the scale-up of advanced therapies that require risk-based, product-specific biosafety strategies. Regulatory expectations from FDA, EMA, ICH, USP, Ph. Eur., and WHO continue to emphasize validated methods, GMP-aligned documentation, contamination control, data integrity, and lifecycle management, making biologics safety testing a core enabler of product approval, batch release, and patient protection.

Transformative Shifts in the Biologics Safety Testing Landscape

The biologics safety testing landscape is shifting from end-point quality control toward integrated contamination control across development, manufacturing, and release. Rapid microbiological methods, molecular assays, next-generation sequencing, automated sample handling, and electronic laboratory workflows are increasingly used alongside compendial tests to improve speed, sensitivity, and investigation quality while maintaining regulatory comparability.

Cell and gene therapies are accelerating this transformation because they often involve short shelf lives, small batch sizes, autologous workflows, viral vectors, complex raw materials, and limited opportunities for extended release testing. At the same time, global outsourcing to specialized CROs, CDMOs, and contract testing laboratories is expanding as sponsors seek validated platforms, biosafety expertise, surge capacity, and integrated support for viral clearance, adventitious virus testing, mycoplasma testing, and GMP release testing.

Cumulative Impact of Artificial Intelligence on Biologics Safety Testing

Artificial intelligence is beginning to influence biologics safety testing through predictive contamination monitoring, anomaly detection in environmental monitoring data, automated review of batch records, and smarter assay development. In high-throughput laboratories, AI-enabled analytics can support trend analysis across sterility, bioburden, endotoxin, viral safety, and mycoplasma datasets, helping quality teams identify deviations earlier and prioritize investigations.

The cumulative impact is operational rather than speculative: AI can reduce manual review burden, improve data integrity checks, support method optimization, and strengthen risk-based quality management when validated within GMP expectations. Adoption remains governed by requirements for explainability, audit trails, cybersecurity, human oversight, and computer system validation, particularly where AI outputs inform release decisions, deviation management, or regulatory submissions.

Key Regional Insights Across Global Biologics Safety Testing

North America remains a leading biologics safety testing hub due to the concentration of biopharmaceutical innovators, FDA-regulated manufacturing, advanced therapy developers, academic translational centers, and specialized contract testing laboratories. The region benefits from mature GMP inspection systems, extensive biologics clinical development, and strong adoption of validated rapid methods for sterility, endotoxin, mycoplasma, and viral safety testing. Europe is similarly mature, supported by EMA oversight, strong national regulatory agencies, the European Pharmacopoeia, and extensive biologics and biosimilar manufacturing across Germany, France, Italy, Spain, and the United Kingdom, with regulatory emphasis on comparability, contamination control strategy, and pharmacopoeial compliance.

Asia-Pacific is one of the most dynamic regions, driven by biologics capacity expansion in China, India, Japan, South Korea, Australia, and ASEAN markets, alongside government support for domestic vaccine production, biosimilars, and advanced therapy development. Latin America is gaining relevance through vaccine production, biosimilar commercialization, public health procurement, and regulatory convergence led by Brazil and Mexico. The Middle East is investing in biomanufacturing localization, healthcare security, and technology transfer programs that increase demand for GMP-aligned safety testing. Africa is building vaccine and biologics quality infrastructure through regional manufacturing initiatives, regulatory strengthening, and international partnerships focused on local production resilience and biologics quality assurance.

Key Group Insights for Biologics Safety Testing Demand

ASEAN is emerging as a manufacturing and clinical development corridor, with Singapore and regional hubs supporting bioprocessing, analytical services, regulatory reliance pathways, and supply chain resilience for biologics and vaccines. The GCC is prioritizing healthcare diversification, life sciences investment, and local pharmaceutical capability, creating demand for GMP testing partnerships, technology transfer, laboratory qualification, and regulatory readiness for biologics, biosimilars, and vaccines.

The European Union benefits from harmonized rules, established pharmacopoeial standards, centralized regulatory procedures, and strong biosimilar experience, making it a reference market for compliance-led safety testing. BRICS countries are central to future development activity because China, India, and Brazil combine large patient populations with expanding biologics manufacturing, while Russia and South Africa maintain policy-driven interest in domestic biologics and vaccine capabilities. G7 markets remain technology leaders in advanced testing platforms, digital quality systems, cell and gene therapy oversight, and high-complexity analytical validation. NATO-aligned countries emphasize secure supply chains, pandemic preparedness, regulatory interoperability, and resilient biopharmaceutical quality systems, reinforcing the role of biologics safety testing in national health security.

Key Country Insights in Biologics Safety Testing

The United States leads in advanced biologics, cell and gene therapy development, FDA-regulated manufacturing, and outsourced biosafety testing capacity, with strong demand for viral safety, sterility, endotoxin, mycoplasma, and release testing services. Canada supports clinical research, vaccine capabilities, regulated biologics manufacturing, and quality systems aligned with international GMP expectations. Mexico is strengthening its role in Latin American pharmaceutical manufacturing and regulatory modernization, while Brazil holds strong regional influence in vaccines, biosimilars, public health procurement, and biologics quality infrastructure.

In Europe, the United Kingdom, Germany, France, Italy, and Spain offer strong regulatory, manufacturing, and clinical trial ecosystems, with Germany and France anchored by advanced bioprocessing capabilities, Italy and Spain supported by established pharmaceutical production networks, and the United Kingdom reinforced by translational research and advanced therapy development. Russia maintains domestic biologics and vaccine capabilities shaped by local policy priorities and supply security objectives. China and India are expanding rapidly through biosimilars, recombinant products, vaccines, CDMO services, and investments in analytical testing capacity. Japan, Australia, and South Korea contribute high-quality regulatory environments, advanced biomanufacturing, strong clinical research systems, and broad adoption of validated analytical technologies for biologics safety testing.

Actionable Recommendations for Biologics Safety Testing Leaders

Vendors should align biologics safety testing strategy with the full product lifecycle, beginning with raw material qualification, cell substrate characterization, viral risk assessment, contamination control planning, and assay suitability evaluation. Sponsors should select partners with proven GMP systems, validated assays, global regulatory experience, robust data integrity controls, and capacity for urgent release testing, especially for advanced therapies, personalized medicines, and short-shelf-life products.

Organizations should also invest in digital quality systems, laboratory information management, method lifecycle management, and risk-based validation of rapid microbiological and molecular methods. Building redundancy across qualified laboratories, harmonizing global specifications, maintaining clear comparability documentation, and engaging regulators early can reduce approval delays, strengthen supply continuity, and improve confidence in biologics safety data. Leaders should prioritize cross-functional governance among quality, regulatory, manufacturing, and analytical development teams to ensure biosafety decisions are scientifically justified and inspection-ready.

Research Methodology for Biologics Safety Testing Analysis

This executive summary is developed from a structured review of verified regulatory frameworks, pharmacopoeial requirements, public agency guidance, industry standards, and observed biopharmaceutical manufacturing trends. The analysis considers FDA, EMA, ICH, USP, Ph. Eur., WHO, PIC/S, and OECD-aligned principles where relevant to sterility, endotoxin, mycoplasma, viral safety, adventitious agent testing, cell substrate characterization, and GMP quality systems.

The methodology combines secondary research, market triangulation, segment mapping, and qualitative assessment of technology adoption across biologics, biosimilars, vaccines, and cell and gene therapies. Insights are evaluated by region, country, and strategic group to identify demand drivers, compliance pressures, outsourcing patterns, regulatory expectations, and operational priorities for biologics safety testing providers and sponsors, while avoiding unsupported market sizing, market share, or forecasting claims.

Conclusion: Strategic Outlook for Biologics Safety Testing

Biologics safety testing is becoming more strategic as products grow more complex, manufacturing networks globalize, and regulators intensify expectations for contamination control, validated methods, and data integrity. The market is supported by durable demand for viral safety testing, sterility testing, endotoxin testing, mycoplasma testing, cell line characterization, residual impurity analysis, and advanced molecular assays across commercial biologics and next-generation therapies.

Organizations that combine scientific rigor, validated technology, regulatory intelligence, and scalable laboratory operations will be best positioned to support faster development, reliable batch release, and sustained patient safety. The strongest competitive advantage will come from integrating compliance, speed, digital traceability, and predictive quality into a unified biosafety testing model that meets evolving global regulatory expectations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biologics Safety Testing Market, by Offering
7.1. Introduction
7.2. Instruments
7.2.1. Endotoxin Readers
7.2.2. PCR Systems
7.2.3. Incubators
7.3. Reagents & Kits
7.4. Services
7.4.1. Implementation
7.4.2. Maintenance & Support
7.5. Solutions
7.5.1. LIMS/QMS Integrations
7.5.2. Assay Analysis
7.5.3. Trend Monitoring
8. Biologics Safety Testing Market, by Test Type
8.1. Introduction
8.2. Adventitious Agent Detection
8.3. Bioburden Testing
8.4. Cell Line Authentication & Characterization
8.5. Endotoxin Testing
8.6. Mycoplasma Testing
8.7. Residual Host Cell Protein (HCP) Testing
8.8. Sterility Testing
9. Biologics Safety Testing Market, by Form
9.1. Introduction
9.2. Kit Format
9.3. Single-vial Reagent Format
10. Biologics Safety Testing Market, by Application
10.1. Introduction
10.2. Gene Therapy
10.3. Monoclonal Antibody Production
10.4. Recombinant Protein Therapeutics
10.5. Stem Cell Research
10.6. Tissue Engineering
10.7. Vaccine Development
11. Biologics Safety Testing Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations (CROs)
11.4. Pharmaceutical & Biotechnology Companies
12. Biologics Safety Testing Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Biologics Safety Testing Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Biologics Safety Testing Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Associates of Cape Cod, Inc.
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux SA
16.6. Bionique Testing Laboratories
16.7. Catalent Inc.
16.8. Charles River Laboratories International, Inc.
16.9. Clean Biologics SAS
16.10. Danaher Corporation
16.11. Eurofins Scientific SE
16.12. FUJIFILM Corporation
16.13. GenScript Biotech Corporation
16.14. Intertek Group plc
16.15. Laboratory Corporation of America Holdings
16.16. Lonza Group AG
16.17. Merck KGaA
16.18. Pace Analytical Services, LLC
16.19. Promega Corporation
16.20. QIAGEN N.V.
16.21. QPS Holdings LLC
16.22. Samsung Biologics Co., Ltd.
16.23. SGS SA
16.24. Syngene International Limited
16.25. Thermo Fisher Scientific Inc.
16.26. Toxikon Corporation
16.27. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ENDOTOXIN READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL IMPLEMENTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL IMPLEMENTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL IMPLEMENTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL LIMS/QMS INTEGRATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ASSAY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TREND MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL TREND MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TREND MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ADVENTITIOUS AGENT DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CELL LINE AUTHENTICATION & CHARACTERIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL RESIDUAL HOST CELL PROTEIN (HCP) TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL STERILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL STERILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL STERILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL KIT FORMAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL KIT FORMAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL KIT FORMAT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SINGLE-VIAL REAGENT FORMAT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GENE THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GENE THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL GENE THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RECOMBINANT PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL VACCINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 110. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 111. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 112. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 113. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 114. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 115. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. EUROPE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 137. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 138. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 139. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 140. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 141. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 142. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 156. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 157. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 158. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 159. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 160. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 161. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. NATO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 165. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 166. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 167. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 168. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 169. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 170. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. G7 BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 174. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 175. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 176. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 177. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 178. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 179. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. BRICS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 192. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 193. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 194. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 195. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 196. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 197. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. ASEAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 201. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 202. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 203. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 204. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 205. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 206. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. GCC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 209. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 211. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 212. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 213. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 214. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 215. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 216. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 229. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 230. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 231. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 232. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 233. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 234. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 238. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 239. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 240. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 241. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 242. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 243. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 247. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 248. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 249. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 250. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 251. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 252. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 265. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 266. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 267. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 268. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 269. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 270. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 274. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 275. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 276. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 277. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 278. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 279. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 283. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 284. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 285. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 286. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 287. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 288. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 292. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 293. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 294. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 295. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 296. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 297. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 301. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 302. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 303. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 304. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 305. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 306. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 310. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 311. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 312. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 313. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 314. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 315. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 319. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 320. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 321. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 322. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 323. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 328. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 329. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 330. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 331. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 332. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 333. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 337. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 338. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 339. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 340. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 341. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 342. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 343. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. GLOBAL BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 345. GLOBAL BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Agilent Technologies, Inc.
  • Associates of Cape Cod, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bionique Testing Laboratories
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Clean Biologics SAS
  • Danaher Corporation
  • Eurofins Scientific SE
  • FUJIFILM Corporation
  • GenScript Biotech Corporation
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Promega Corporation
  • QIAGEN N.V.
  • QPS Holdings LLC
  • Samsung Biologics Co., Ltd.
  • SGS SA
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.09 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Biologics Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Biologics Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Biologics CXO Services Market - Global Forecast 2026-2032 - Product Image

Biologics CXO Services Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Biologics Safety Testing Market by Product, Services, Test Type, Product & Services by Application, End User, Competition, Region - Global Forecast to 2031 - Product Image

Biologics Safety Testing Market by Product, Services, Test Type, Product & Services by Application, End User, Competition, Region - Global Forecast to 2031

  • Report
  • 527 Pages
  • Global
From
Biologics Safety Testing Market by Type of Offering, Type of Testing, Type of Modality, Type of Technology and Geographical Regions - Trends and Forecast, Till 2035 - Product Image

Biologics Safety Testing Market by Type of Offering, Type of Testing, Type of Modality, Type of Technology and Geographical Regions - Trends and Forecast, Till 2035

  • Report
  • 260 Pages
  • Global
From
Biologics Safety Testing - Global Strategic Business Report - Product Image

Biologics Safety Testing - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From

About the Biologics Safety Testing Market

The Biologics Safety Testing market is a subset of the biopharmaceuticals industry, which focuses on the development and production of biological drugs. These drugs are derived from living organisms, such as bacteria, viruses, and other cells, and are used to treat a variety of diseases. Biologics Safety Testing is a critical step in the development of these drugs, as it ensures that the drug is safe for human use. This testing involves assessing the safety of the drug in terms of its toxicity, immunogenicity, and efficacy. It also involves assessing the stability of the drug, as well as its ability to be stored and transported. Companies in the Biologics Safety Testing market include Charles River Laboratories, Eurofins Scientific, SGS, WuXi AppTec, and BioReliance. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.